LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris
Public ClinicalTrials.gov record NCT02899962. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A phase 3 trial comparing the efficacy and safety of LEO 90100 aerosol foam with the aerosol foam vehicle used twice weekly as long-term maintenance therapy in subjects with psoriasis vulgaris. A 12-month, international, multi-centre, randomised, vehicle controlled, double-blind, 2-arm, parallel group trial.
Study identification
- NCT ID
- NCT02899962
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 722 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2017 (Actual)
- Primary completion
- Jun 26, 2019 (Actual)
- Completion
- Jun 26, 2019 (Actual)
- Last update posted
- Aug 20, 2020
2017 – 2019
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Center for Dermatology Clinical Research | Fremont | California | 94538 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Colorado Medical Research Center | Denver | Colorado | 80210 | — |
| International Dermatology Research | Miami | Florida | 33144 | — |
| Arlington Dermatology | Arlington Heights | Illinois | 60005 | — |
| Derm Research | Louisville | Kentucky | 40217 | — |
| DermAssociates | Rockville | Maryland | 20850 | — |
| Clarkston Skin Research | Clarkston | Michigan | 48346 | — |
| Henry Ford Medical Center - New Center One | Detroit | Michigan | 48202 | — |
| Beyer Research | Kalamazoo | Michigan | 49009 | — |
| Psoriasis Treatment Center of Central NJ | East Windsor | New Jersey | 08520 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| Sadick Research Group | New York | New York | 10075 | — |
| Skin Search of Rochester | Rochester | New York | 14623 | — |
| UPMC Department of Dermatology | Pittsburgh | Pennsylvania | 15213 | — |
| Rivergate Dermatology Clinical Research Center | Goodlettsville | Tennessee | 37072 | — |
| The Skin Wellness Center | Knoxville | Tennessee | 37922 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Clinical Trials of Texas | San Antonio | Texas | 78229 | — |
| Center for Clinical Studies | Webster | Texas | 77598 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02899962, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2020 · Synced Nov 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02899962 live on ClinicalTrials.gov.